Global CDMO Presence AGC Pharma Chemicals operates in Spain and Japan as a small molecule API and intermediate CDMO with a 60+ year history, offering established manufacturing capabilities and international reach that can support multinational pharma companies seeking reliable outsourcing partners.

Expansion & Capabilities Recent facility expansion in Barcelona and development of a next‑generation API/HPAPI manufacturing site highlight capacity growth and investment in advanced small molecule production, presenting opportunities for customers seeking scalable manufacturing and enhanced HPAPI handling.

Industry Recognition Four Best in Class distinctions at the CDMO Leadership Awards 2026 across staff, culture, technology use, and scaling support signal strong operational excellence and differentiators that can reassure potential clients evaluating outsourcing partners.

Engagement & Events Active participation in major industry events (DCAT Week, BIO International Convention, BOS Basel, BOS Manchester, Connection Day) demonstrates ongoing business development activity and a pipeline of collaboration opportunities with biotech, small/mid‑size molecule developers, and global pharma.

Financial Scale With revenue in the mid‑range for a CDMO and a mid‑sized employee base, AGC Pharma Chemicals positions itself as a cost‑effective partner for mid to large‑volume small molecule APIs and HPAPI programs, appealing to growing companies seeking reliable cost performance.